ArticleEpidemiology and infection2013
Dengue infections in non-immune travellers to Thailand.
Article in Epidemiology and infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 31 citations in OpenAlex.
- Estimating the incidence of dengue in international air travelers from non-endemic countries between 2010-2019.PLoS neglected tropical diseases · 2025Article
- Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.PLoS medicine · 2025Article
- A Cluster of Dengue Cases in Travelers: A Clinical Series from Thailand.Tropical medicine and infectious disease · 2021Article
- Risks Related to Chikungunya Infections among European Union Travelers, 2012-2018.Emerging infectious diseases · 2020Article
- Risk of yellow fever virus importation into the United States from Brazil, outbreak years 2016-2017 and 2017-2018.Scientific reports · 2019Article
- Novel tools for the surveillance and control of dengue: findings by the DengueTools research consortium.Global health action · 2018Article
- On the origin and timing of Zika virus introduction in Brazil.Epidemiology and infection · 2017Article
- ZikaPLAN: Zika Preparedness Latin American Network.Global health action · 2017Article
- A New Look at an Old Disease: Recent Insights into the Global Epidemiology of Dengue.Current epidemiology reports · 2017Review
- Modelling the risk of transfusion transmission from travelling donors.BMC infectious diseases · 2016Article
- Modeling Importations and Exportations of Infectious Diseases via Travelers.Bulletin of mathematical biology · 2016Article
- Dengue: update on epidemiology.Current infectious disease reports · 2015Article
- Theoretical impact of insecticide-impregnated school uniforms on dengue incidence in Thai children.Global health action · 2013Article
- Estimated Zika virus importations to Europe by travellers from Brazil.Global health actionArticle
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 2 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is the most frequent arboviral disease and is expanding geographically. Dengue is also increasingly being reported in travellers, in particular in travellers to Thailand. However, data to quantify the risk of travellers acquiring dengue when travelling to Thailand are lacking. Using mathematical modelling, we set out to estimate the risk of non-immune persons acquiring dengue when travelling to Thailand. The model is deterministic with stochastic parameters and assumes a Poisson distribution for the mosquitoes' biting rate and a Gamma distribution for the probability of acquiring dengue from an infected mosquito. From the force of infection we calculated the risk of dengue acquisition for travellers to Thailand arriving in a typical year (averaged over a 17-year period) in the high season of transmission. A traveller arriving in the high season of transmission and remaining for 7 days has a risk of acquiring dengue of 0·2% (95% CI 0·16-0·23), whereas the risk for travel of 15 and 30 days' duration is 0·46% (95% CI 0·41-0·50) and 0·81% (95% CI 0·76-0·87), respectively. Our data highlight that the risk of non-immune travellers acquiring dengue in Thailand is substantial. The incidence of 0·81% after a 1-month stay is similar to that reported in prospective seroconversion studies in Israeli travellers to Thailand, highlighting that our models are consistent with actual data. Risk estimates based on mathematical modelling offer more detailed information depending on various travel scenarios, and will help the travel medicine provider give better evidence-based advice for travellers to dengue-endemic countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.